1995
DOI: 10.1016/8756-3282(95)00329-c
|View full text |Cite
|
Sign up to set email alerts
|

The effect of ovariectomy on bone metabolism in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

13
57
1
1

Year Published

1998
1998
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 84 publications
(74 citation statements)
references
References 9 publications
13
57
1
1
Order By: Relevance
“…Although the administration of APS increased the uterine weight compared to that of the OVX group, it was still lower than that of the Sham group. Furthermore, a previous study showed that the body weight gain in OVX rats increased significantly compared with that in the Sham rats (Omi and Ezawa, 1995). In line with this study, we found that the OVX group showed a significant increase in body weight gain than the Sham group did.…”
Section: Discussionsupporting
confidence: 81%
“…Although the administration of APS increased the uterine weight compared to that of the OVX group, it was still lower than that of the Sham group. Furthermore, a previous study showed that the body weight gain in OVX rats increased significantly compared with that in the Sham rats (Omi and Ezawa, 1995). In line with this study, we found that the OVX group showed a significant increase in body weight gain than the Sham group did.…”
Section: Discussionsupporting
confidence: 81%
“…The LF treatment did not cause differentiation of the bone marrow stromal cells to an osteoblastic lineage in this ovariectomized rat model. According to previous studies [3] , however, the inhibition of bone resorption markers by oral LF suggests that LF may prevent Ovx-induced bone loss via a preferential anti-osteoclastogenic pathway.…”
Section: Discussionmentioning
confidence: 99%
“…The bone loss is caused by an imbalance between the activities of osteoclasts and osteoblasts, and it leads to the uncoupling of bone resorption and bone formation [2] . The bone loss found in postmenopausal osteoporosis (PMOP) cases is caused by estrogen deficiency that increases osteoclast activity and bone remodeling -a predominance of bone resorption over bone formation [3] . The increased rate of bone turnover as observed from markers, such as β-CrossLaps (β-CTx) and collagen type I N-telopeptide (NTX), may be an additional risk factor for fractures by exacerbating bone loss.…”
Section: Introductionmentioning
confidence: 99%
“…A recent study by Fujimura et al 22 has been reported that the local administration of alendronate sodium hydrate has inhibited orthodontic tooth movement and root resorption in male mice. Classically, ovariectomized rats have been advocated as a good osteoporotic animal model 23 and often have been used to study efficacy of drugs aimed to prevent bone loss. 16,[24][25][26][27][28] Due to the similarity among of the morphology and function of the cells, in both, root resorption and bone resorption processes could be considered similar.…”
Section: Introductionmentioning
confidence: 99%